3rd International Conference on
Microbiology & Infectious Diseases
Nov 27-28, 2023
Dubai,UAE
microbiology@averconferences.com
Crowne Plaza Dubai-Deira
With the grand success from the previous relevant worldwide conferences, Aver Conferences is organizing “3rd International Conference on Microbiology & Infectious Diseases" which will be held on November 27-28, 2023 in Dubai, UAE.
Microbiology & Infectious congress 2023 brings together the global leaders in Microbiology & Infectious Diseases fields to present their research at this exclusive scientific program. The conference delivers an opportunity to researchers and experts to discover the basic, innovative and latest research developments in the field of Current Trends in Microbiology and Infectious Diseases.
Microbiology
Infectious Diseases
Medical Microbiology
Causes and Symptoms of Infectious Diseases
Clinical Microbiology
Infection Prevention, Control and Cure
Pharmaceutical Microbiology
Pediatric / Childhood Infectious Diseases
Agricultural Microbiology
Bacterial/Viral/Fungal Infectious Diseases
Pathogenicity of Microbes
Veterinary Infectious Diseases
Microbiology Research and Advancements
Antimicrobials/ Antibiotics/ Antibacterial
Environmental Microbiology
University of Trás-os-Montes and Alto Douro
Portugal
University of Tras-os-Montes and Alto Douro
Portugal
Central Veterinary Research Laboratory
Sudan
Assiut University
Egypt
Marien Ngouabi University
Congo
Sotira Scientific
USA
Bulacan State University
Phillipines
Redhill Biopharma, Ltd
Israel
"Title: Analysis of Resistance and Virulence Genes of Gram-Positive Bacteria Detected in Calf Colostrums"
"Title: Genotypic Characterization of Gram-Positive Bacteria isolated on Ornamental Animals Feed"
“Title: Sero-epidemiological survey of bluetongue disease in one-humped camel (Camelus dromedarius) in Kassala State, Eastern Sudan"
"Title: First description of Extended-Spectrum β-lactamases and OXA-48 carbapenemase in Enterobacteriaceae isolates in Brazzaville, Congo"
"Title: Antifungal and Anti-Biofilm Activity of Essential Oil against Candida"
"Title: Characterizing the Impact of COVID-19 on the Global Stock Indices through Comparative Analysis"
"Title: Abc-201: Opaganib, A Sphingosine Kinase-2 (Sk2) Inhibitor In Covid-19 Pneumonia: A Randomized, Double-Blind,Placebo-Controlled Phase 2/3 Study, In Adult Subjects "
